rivastigmine has been researched along with humulene in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ludin, HP | 1 |
Blokland, A; de Sousa Fernandes Perna, EB; Heckman, P; Kuypers, KP; Prickaerts, J; Ramaekers, JG; Sambeth, A; Theunissen, EL; Toennes, SW | 1 |
1 review(s) available for rivastigmine and humulene
Article | Year |
---|---|
[Are there innovations in the treatment of Parkinson's disease?].
Topics: Antiparkinson Agents; Cannabis; Cholinesterase Inhibitors; Controlled Clinical Trials as Topic; Dopamine Agonists; Heart Valve Diseases; Humans; Indans; Levodopa; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Pergolide; Phenylcarbamates; Placebos; Rivastigmine; Time Factors | 2004 |
1 trial(s) available for rivastigmine and humulene
Article | Year |
---|---|
Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans.
Topics: Acetylcholine; Adult; Attention; Cannabinoids; Cannabis; Cognition; Cross-Over Studies; Double-Blind Method; Female; Glutamic Acid; Humans; Imidazoles; Male; Marijuana Smoking; Memory; Memory Disorders; Memory, Short-Term; Phenylcarbamates; Piperazines; Prospective Studies; Rivastigmine; Sulfones; Triazines; Vardenafil Dihydrochloride; Verbal Learning; Young Adult | 2015 |